217 related articles for article (PubMed ID: 37930705)
21. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.
Lim AS; Yu L; Kowgier M; Schneider JA; Buchman AS; Bennett DA
JAMA Neurol; 2013 Dec; 70(12):1544-51. PubMed ID: 24145819
[TBL] [Abstract][Full Text] [Related]
22. Risk of dementia among white and African American relatives of patients with Alzheimer disease.
Green RC; Cupples LA; Go R; Benke KS; Edeki T; Griffith PA; Williams M; Hipps Y; Graff-Radford N; Bachman D; Farrer LA;
JAMA; 2002 Jan; 287(3):329-36. PubMed ID: 11790212
[TBL] [Abstract][Full Text] [Related]
23. Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.
Rajabli F; Feliciano BE; Celis K; Hamilton-Nelson KL; Whitehead PL; Adams LD; Bussies PL; Manrique CP; Rodriguez A; Rodriguez V; Starks T; Byfield GE; Sierra Lopez CB; McCauley JL; Acosta H; Chinea A; Kunkle BW; Reitz C; Farrer LA; Schellenberg GD; Vardarajan BN; Vance JM; Cuccaro ML; Martin ER; Haines JL; Byrd GS; Beecham GW; Pericak-Vance MA
PLoS Genet; 2018 Dec; 14(12):e1007791. PubMed ID: 30517106
[TBL] [Abstract][Full Text] [Related]
24. Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease.
Zissimopoulos JM; Barthold D; Brinton RD; Joyce G
JAMA Neurol; 2017 Feb; 74(2):225-232. PubMed ID: 27942728
[TBL] [Abstract][Full Text] [Related]
25. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
[TBL] [Abstract][Full Text] [Related]
26. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
28. Race-Related Association between APOE Genotype and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Qin W; Li W; Wang Q; Gong M; Li T; Shi Y; Song Y; Li Y; Li F; Jia J
J Alzheimers Dis; 2021; 83(2):897-906. PubMed ID: 34334408
[TBL] [Abstract][Full Text] [Related]
29. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial.
Raman R; Quiroz YT; Langford O; Choi J; Ritchie M; Baumgartner M; Rentz D; Aggarwal NT; Aisen P; Sperling R; Grill JD
JAMA Netw Open; 2021 Jul; 4(7):e2114364. PubMed ID: 34228129
[TBL] [Abstract][Full Text] [Related]
30. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.
Evans DA; Bennett DA; Wilson RS; Bienias JL; Morris MC; Scherr PA; Hebert LE; Aggarwal N; Beckett LA; Joglekar R; Berry-Kravis E; Schneider J
Arch Neurol; 2003 Feb; 60(2):185-9. PubMed ID: 12580702
[TBL] [Abstract][Full Text] [Related]
31. Associations of Alzheimer Disease-Protective APOE Variants With Age-Related Macular Degeneration.
Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
JAMA Ophthalmol; 2023 Jan; 141(1):13-21. PubMed ID: 36394841
[TBL] [Abstract][Full Text] [Related]
32. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.
Reitz C; Jun G; Naj A; Rajbhandary R; Vardarajan BN; Wang LS; Valladares O; Lin CF; Larson EB; Graff-Radford NR; Evans D; De Jager PL; Crane PK; Buxbaum JD; Murrell JR; Raj T; Ertekin-Taner N; Logue M; Baldwin CT; Green RC; Barnes LL; Cantwell LB; Fallin MD; Go RC; Griffith P; Obisesan TO; Manly JJ; Lunetta KL; Kamboh MI; Lopez OL; Bennett DA; Hendrie H; Hall KS; Goate AM; Byrd GS; Kukull WA; Foroud TM; Haines JL; Farrer LA; Pericak-Vance MA; Schellenberg GD; Mayeux R;
JAMA; 2013 Apr; 309(14):1483-92. PubMed ID: 23571587
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
[TBL] [Abstract][Full Text] [Related]
35. Association of apolipoprotein E genotype and Alzheimer disease in African Americans.
Murrell JR; Price B; Lane KA; Baiyewu O; Gureje O; Ogunniyi A; Unverzagt FW; Smith-Gamble V; Gao S; Hendrie HC; Hall KS
Arch Neurol; 2006 Mar; 63(3):431-4. PubMed ID: 16533971
[TBL] [Abstract][Full Text] [Related]
36. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.
Polito L; Kehoe PG; Davin A; Benussi L; Ghidoni R; Binetti G; Quadri P; Lucca U; Tettamanti M; Clerici F; Bagnoli S; Galimberti D; Nacmias B; Sorbi S; Guaita A; Scarpini E; Mariani C; Forloni G; Albani D
Alzheimers Dement; 2013 Jul; 9(4):392-9. PubMed ID: 22651940
[TBL] [Abstract][Full Text] [Related]
37. Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region.
Hittle M; Culpepper WJ; Langer-Gould A; Marrie RA; Cutter GR; Kaye WE; Wagner L; Topol B; LaRocca NG; Nelson LM; Wallin MT
JAMA Neurol; 2023 Jul; 80(7):693-701. PubMed ID: 37184850
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.
Morris JC; Schindler SE; McCue LM; Moulder KL; Benzinger TLS; Cruchaga C; Fagan AM; Grant E; Gordon BA; Holtzman DM; Xiong C
JAMA Neurol; 2019 Mar; 76(3):264-273. PubMed ID: 30615028
[TBL] [Abstract][Full Text] [Related]
39. Racial, Ethnic, and Socioeconomic Differences in Food Allergies in the US.
Jiang J; Warren CM; Brewer A; Soffer G; Gupta RS
JAMA Netw Open; 2023 Jun; 6(6):e2318162. PubMed ID: 37314805
[TBL] [Abstract][Full Text] [Related]
40. Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults.
Kaup AR; Nettiksimmons J; Harris TB; Sink KM; Satterfield S; Metti AL; Ayonayon HN; Yaffe K;
JAMA Neurol; 2015 Mar; 72(3):340-8. PubMed ID: 25599330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
